Just had my 1st infusion of Lutetium- 177, 3/9/23, in the Eclipse Trial.
Received 216.0 mCi of Lutetium- 177, after receiving ondansetron (Zofran) (for possible nausea) & 0.9% Saline Solution. Continued the Saline Solution for 1 hr. after infusion, also.
The Technician said the LU 177 was manufactured in Finland.
So far no side effects. No dry mouth, nausea, tiredness, etc. Knock on Wood! 😀
See Bio for more details, but basically, after 6 months of Apalutamide & Lupron, PSA went from 0.1 (after falling from 7.3) to 0.6. Following PSMA PET scan it was obvious I was MCRPC.
MO recommended me for Eclipse Trial, started at St. Louis U's "Center of Excellence in Radiopharmaceutical Therapy" & was accepted. Went from PSA of 1.1, at Eclipse screening lab work to 2.0 yesterday. Received the "long straw" & was immediately placed on the study drug vs. SOC.
Will receive 2nd infusion in 6 weeks. Will keep Bio up to date on progress.
Written by
john4803
To view profiles and participate in discussions please or .
Is the ECLIPSE trial for men who are castrate resistant who have never had chemotherapy? If so, there are a lot of clinical trials going on right now that are looking to have Lutetium-177 (Pluvicto) given much earlier in your treatment plan than currently approved by the FDA and Health Canada. I am currently participating in the world-wide SPLASH trial which sounds as if it has a very similar objective to ECLIPSE. Not quite sure what the difference is.
...pre-chemotherapy? If so your trial has exactly the same objective(s) as the SPLASH clinical trial that I am on. The Germans, Australians, British and most of the world for that matter use Pluvicto (Lutetium-177) to treat prostate cancer much earlier than what it is currently approved for in North America. Good luck!
hey John! I hope this trial brings you great results. One question—- you haven’t had chemo right? I’m trying to see what’s available for my dad who’s castrate resistant other than chemotherapy.
Correct, I have not had Chemo! My MO told me Chemo only lasts 8-12 months, typically and LU177 is better. So, he recommended me for it, instead.
Dr. Kwon (Mayo), says in a Youtube video that the rule has wiggle room and that you don't actually have to fail Chemo but at least try it, even for a short period.
It probably all depends on the health care system or insurance company's interpretation, however?
Good question, Wilson? I can't seem to find a definitive answer? My MO thinks it lasts longer than Chemo because he recommended me for the trial but he does not have experience with it himself. The Vision trial is not very reliable according to my trial Doc. because they were pretty sick participants.
It is truly a scary time for you as you struggle with this "plague-like" disease. Our hearts go out to you and your husband!
My care team, in the Eclipse Trial told me only trials are getting LU177 reasonably soon in the US. They are not taking on any new patients (having failed Chemo), at this time. I consider myself extremely lucky to have qualified for this study when I did!
I failed to have my PSA tested when I should have, due too a time when the test was discouraged by Docs. and Insurance companies (early 2000's). As a result, it had left the Prostate and now I will battle it for life. Unless they come up with immunotherapy, I guess?
Hopefully, he can hang on until they come up with the "magic bullet"?
Thanks for that information. So same trial, different drug companies. I thought Novartis had the exclusive rights to market Lutetium in North America but obviously there are other drug companies wanting to get in the mix. We can only hope that both trials have similar outcomes that will lead to Pluvicto (Lutetium-177) being approved for men much earlier in their treatment plan and pre-chemotherapy..
I was in the Splash trial last fall. Excellent results from dose 1, then dose 2 was positive but not great. Dose 3 gave me bad reaction of very severe bone pain, then mo did a new scan and found progression. So I was moved out of the trial and on to SOC chemo.
Wishing all the LU patients a great result and long long remission
during the splash trial per their rules, they did not share psa with me or even my mo. However before dose 1 it was mid 30s. After dose 3 and trial ended early for me due to progression on scan it was 72
I decided not to put up much bio because of a stalker on the site that was using the info to try and start arguments
Good luck with your trials. I was told by my trial coordinator that of the 20 enrolled locally, she had seen really good response in 5, mixed results in 9, and 6 including me that had to leave the trial either because of negative side effects or progression during the trial.
Don't confuse lutetium (the radioisotope), which is made all over the place, with the radioligand used to treat prostate cancer. Novartis has rights to the lutetium-labeled PSMA-617 ligand, making 177Lu-PSMA-617. The SPLASH and ECLIPSE trials are using a different ligand, PSMA-I&T. They use 177Lu-PSMA-PNT2002 and 177Lu-PSMA-I&T, respectively. My understanding is that I&T and PNT2002 are the same but named differently for some unknown reason.
The Eclipse Trial uses only 4 infusions. Not sure about the Splash. But I think with Pluvicto there are 6. Could this be a difference, too? Thanks, for the detail, however!
That makes a whole lot of sense. Thanks for clearing up my confusion. I did not make the distinction in my head between the radioisotope and the ligand. I was wondering how Novartis got exclusivity in North America to a drug (Lutetium-177) which is in use world-wide.
So they're starting dosing again with LU 177! Great news. Quick question: the tech said the LU 177 was manufactured in Finland. My understanding is that the recent manufacturing problem has been with the targeting molecule (which is proprietary to Novartis) not with the LU 177 (radioactive substance) which is manufactured in many places. Do you know if the tech was referring to the targeting molecule or the the LU 177?
No, sorry, but she just looked at the small "coffee-shaped" can it came in and read the info. on it saying, "made in Finland". Don't know anymore than that. Will ask at my next visit. Sorry!
See my note on SLU is not taking anymore patients for LU177, except for trials, at this time.
I had my 2nd treatment for the Eclipse Trial today. Interesting that you got saline for an hour afterwards, I didn't get that but really didn't want to sit there for another hour. My PSA 1 month after my first treatment was 0.02, down from 21 something. I was super happy with that.
No, I have followed SOC for the last 7 years, including ADT, surgery, and radiation. The only thing left at this point was chemo. This study allowed me to do Lu177 before doing chemo.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Blood Test results -3 weeks after 2nd LU-177 infusion
Update-1st infusion Lu -617
Results of Second Fusion of LU-177
